Last updated on November 2017

A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS)


Brief description of study

A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS)

Detailed Study Description

The primary purpose of this study is to evaluate whether treatment with rivaroxaban and aspirin or rivaroxaban alone is better than aspirin alone in prevention of heart attacks, stroke or cardiovascular death in patients with coronary or peripheral artery disease.

Clinical Study Identifier: TX4761

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Wendy Schneider, MSN, RN, CCRC

Holy Cross Jim Moran Heart and Vascular Research Institute
Coral Springs, FL USA
  Connect »